menu
    • menu

    Company profile for Kuros Biosciences

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Today, nearly 1 in 5 spinal fusions fail. But what can we do to change this situation - for the benefit of patients, surgeons and our wider society? This is the question that drives us at Kuros. Every day our team works across three continents to unlock the hidden secrets of bone healing through our research, development & technology program: Project Fusion. To deliver the ideal bone graft, we believe you need the highest qual...
    Today, nearly 1 in 5 spinal fusions fail. But what can we do to change this situation - for the benefit of patients, surgeons and our wider society? This is the question that drives us at Kuros. Every day our team works across three continents to unlock the hidden secrets of bone healing through our research, development & technology program: Project Fusion. To deliver the ideal bone graft, we believe you need the highest quality & quantity of scientific evidence behind it. Which is why Project Fusion brings together an unprecedented blend of scientific, pre-clinical and clinical studies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kuros BiosciencesSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Wagistrasse 25, 8952 Schlieren, Switzerland
    Telephone
    Telephone
    +41 (0)44 733 4747
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kurosbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kurosbiosciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    India Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    India Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kuros Biosciences Agm Approves All Resolutions
    Kuros Biosciences Agm Approves All Resolutions

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274483/0/en/Annual-General-Meeting-of-Kuros-Biosciences-approves-all-resolutions.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Kuros Biosciences Sees 51% Sales Surge In Q1 2026
    Kuros Biosciences Sees 51% Sales Surge In Q1 2026

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3272998/0/en/Kuros-Biosciences-reports-51-year-over-year-increase-in-sales-in-the-first-three-months-of-2026.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Kuros Biosciences Achieves 72% Sales Growth, Hits $146.1M In 2025
    Kuros Biosciences Achieves 72% Sales Growth, Hits $146.1M In 2025

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252432/0/en/Kuros-Biosciences-delivers-72-year-over-year-sales-growth-reaching-USD-146-1-million-for-2025.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Kuros Biosciences Shares Updates at Octavian & Baader Conferences
    Kuros Biosciences Shares Updates at Octavian & Baader Conferences

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217459/0/en/Kuros-Biosciences-to-provide-investor-update-at-Octavian-and-Baader-Bank-Conferences.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Kuros Enrolls First Patient in Global ASTRA Foot & Ankle Trial
    Kuros Enrolls First Patient in Global ASTRA Foot & Ankle Trial

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197582/0/en/Kuros-Biosciences-announces-enrollment-of-first-patient-in-ASTRA-study-A-global-prospective-randomized-multi-center-clinical-trial-in-foot-and-ankle-fusion.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    Kuros Biosciences Presents at Piper Sandler Healthcare Conference
    Kuros Biosciences Presents at Piper Sandler Healthcare Conference

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3194846/0/en/Kuros-Biosciences-to-present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search